A lack of association between the IKZF2 rs12619285 polymorphism and coronary heart disease

Por YE, HUADAN, HONG, QINGXIAO, LI, YIRUN, XU, XUTING, HUANG, YI, XU, LIMIN, ZHOU, ANNAN, DENG, YOUPING, DUAN, SHIWEI
Publicado no Exp Ther Med (2015)

APC2 and CYP1B1 methylation changes in the bone marrow of acute myeloid leukemia patients during chemotherapy

Por Xia, Yongming, Hong, Qingxiao, Chen, Xiaoying, Ye, Huadan, Fang, Lili, Zhou, Annan, Gao, Yuting, Jiang, Danjie, Duan, Shiwei
Publicado no Exp Ther Med (2016)

CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapy

Por HONG, QINGXIAO, LI, YIRUN, CHEN, XIAOYING, YE, HUADAN, TANG, LINLIN, ZHOU, ANNAN, HU, YAN, GAO, YUTING, CHEN, RONGRONG, XIA, YONGMING, DUAN, SHIWEI
Publicado no Exp Ther Med (2016)

Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis

Por Ye, Huadan, Zhou, Annan, Hong, Qiangxiao, Tang, Linlin, Xu, Xuting, Xin, Yanfei, Jiang, Danjie, Dai, Dongjun, Li, Yirun, Wang, Dao Wen, Duan, Shiwei
Publicado no PLoS One (2015)

Association between the methylation status of the MGMT promoter in bone marrow specimens and chemotherapy outcomes of patients with acute myeloid leukemia

Por HONG, QINGXIAO, CHEN, XIAOYING, YE, HUADAN, ZHOU, ANNAN, GAO, YUTING, JIANG, DANJIE, WU, XIAODONG, TIAN, BINGRU, CHEN, YOUFEN, WANG, MING, XIE, JIPING, XIA, YONGMING, DUAN, SHIWEI
Publicado no Oncol Lett (2016)